标题
Perspectives From Systems Biology to Improve Knowledge of Leishmania Drug Resistance
作者
关键词
-
出版物
Frontiers in Cellular and Infection Microbiology
Volume 11, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2021-04-30
DOI
10.3389/fcimb.2021.653670
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani
- (2020) Jade-Eva Potvin et al. CLINICAL INFECTIOUS DISEASES
- The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression
- (2020) Baibaswata Saha et al. CYTOKINE
- Unveiling six potent and highly selective antileishmanial agents via the open source compound collection ‘Pathogen Box’ against antimony-sensitive and -resistant Leishmania braziliensis
- (2020) Juliano A. Souza Silva et al. BIOMEDICINE & PHARMACOTHERAPY
- Comparative transcriptomic analysis of antimony resistant and susceptible Leishmania infantum lines
- (2020) Juvana Moreira Andrade et al. Parasites & Vectors
- An integrative approach using systems biology, mutational analysis with molecular dynamics simulation to challenge the functionality of a target protein
- (2019) Nikita Bora et al. Chemical Biology & Drug Design
- From biophysics to ‘omics and systems biology
- (2019) Marko Djordjevic et al. EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS
- Building protein-protein interaction networks for Leishmania species through protein structural information
- (2018) Crhisllane Rafaele dos Santos Vasconcelos et al. BMC BIOINFORMATICS
- Leishmaniasis treatment update of possibilities for drug repurposing
- (2018) Eduardo Caio Torres-Santos Frontiers in Bioscience-Landmark
- Transcription Factor Target Gene Network governs the Logical Abstraction Analysis of the Synthetic Circuit in Leishmaniasis
- (2018) Milsee Mol et al. Scientific Reports
- Ascorbate peroxidase overexpression protects Leishmania braziliensis against trivalent antimony effects
- (2018) Douglas de Souza Moreira et al. MEMORIAS DO INSTITUTO OSWALDO CRUZ
- A systematic reconstruction and constraint-based analysis of Leishmania donovani metabolic network: identification of potential antileishmanial drug targets
- (2017) Mahesh Sharma et al. Molecular BioSystems
- Laboratory confirmed miltefosine resistant cases of visceral leishmaniasis from India
- (2017) Saumya Srivastava et al. Parasites & Vectors
- Gene Expression in Leishmania Is Regulated Predominantly by Gene Dosage
- (2017) Stefano A. Iantorno et al. mBio
- HISP: a hybrid intelligent approach for identifying directed signaling pathways
- (2017) Xing-Ming Zhao et al. Journal of Molecular Cell Biology
- Leishmaniasis in humans: drug or vaccine therapy?
- (2017) Masoud Ghorbani et al. Drug Design Development and Therapy
- Drug resistance and treatment failure in leishmaniasis: A 21st century challenge
- (2017) Alicia Ponte-Sucre et al. PLoS Neglected Tropical Diseases
- Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review
- (2017) Nayara Castelano Brito et al. PLoS One
- Molecular characterization and functional analysis of pteridine reductase in wild-type and antimony-resistant Leishmania lines
- (2016) Douglas de Souza Moreira et al. EXPERIMENTAL PARASITOLOGY
- Genomic and Molecular Characterization of Miltefosine Resistance in Leishmania infantum Strains with Either Natural or Acquired Resistance through Experimental Selection of Intracellular Amastigotes
- (2016) Annelies Mondelaers et al. PLoS One
- Functional analysis of iron superoxide dismutase-A in wild-type and antimony-resistant Leishmania braziliensis and Leishmania infantum lines
- (2015) N.G. Tessarollo et al. PARASITOLOGY INTERNATIONAL
- Phosphoproteomic analysis of wild-type and antimony-resistantLeishmania braziliensislines by 2D-DIGE technology
- (2015) Douglas de Souza Moreira et al. PROTEOMICS
- Arsenic Exposure and Outcomes of Antimonial Treatment in Visceral Leishmaniasis Patients in Bihar, India: A Retrospective Cohort Study
- (2015) Meghan R. Perry et al. PLoS Neglected Tropical Diseases
- Elucidation of Cellular Mechanisms Involved in Experimental Paromomycin Resistance in Leishmania donovani
- (2014) V. Bhandari et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and –susceptible Leishmania braziliensis and Leishmania infantum lines
- (2014) Juvana M Andrade et al. Parasites & Vectors
- The Genome Sequence of Leishmania (Leishmania) amazonensis: Functional Annotation and Extended Analysis of Gene Models
- (2013) F. Real et al. DNA RESEARCH
- Comparative proteomic analysis of antimony-resistant and -susceptible Leishmania braziliensis and Leishmania infantum chagasi lines
- (2013) Fabiana S.V. Matrangolo et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Proteomic and Genomic Analyses of Antimony Resistant Leishmania infantum Mutant
- (2013) Marie-Christine Brotherton et al. PLoS One
- In vitro Antileishmanial Drug Susceptibility of Clinical Isolates from Patients with Indian Visceral Leishmaniasis—Status of Newly Introduced Drugs
- (2012) Vijay Kumar Prajapati et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- The Schistosoma mansoni phylome: using evolutionary genomics to gain insight into a parasite’s biology
- (2012) Larissa Silva et al. BMC GENOMICS
- Liposomal amphotericin B as a treatment for human leishmaniasis
- (2012) Manica Balasegaram et al. EXPERT OPINION ON EMERGING DRUGS
- Greater binding affinity of trivalent antimony to a CCCH zinc finger domain compared to a CCHC domain of kinetoplastid proteins
- (2012) Frédéric Frézard et al. Metallomics
- Computational Prediction of Protein-Protein Interactions in Leishmania Predicted Proteomes
- (2012) Antonio M. Rezende et al. PLoS One
- Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani
- (2011) Bidyut Purkait et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Differential expression of proteins in antimony-susceptible and -resistant isolates of Leishmania donovani
- (2011) Neha Biyani et al. MOLECULAR AND BIOCHEMICAL PARASITOLOGY
- Proteome mapping of overexpressed membrane-enriched and cytosolic proteins in sodium antimony gluconate (SAG) resistant clinical isolate of Leishmania donovani
- (2010) Awanish Kumar et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Taking a Systems Approach to the Identification of Novel Therapeutic Targets and Biomarkers
- (2010) David A. Dunn et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Assessing aquaglyceroporin gene status and expression profile in antimony-susceptible and -resistant clinical isolates of Leishmania donovani from India
- (2010) S. Mandal et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Geographical Variation in the Response of Visceral Leishmaniasis to Paromomycin in East Africa: A Multicentre, Open-Label, Randomized Trial
- (2010) Asrat Hailu et al. PLoS Neglected Tropical Diseases
- What is systems biology?
- (2010) Rainer Breitling Frontiers in Physiology
- Philosophical Basis and Some Historical Aspects of Systems Biology: From Hegel to Noble - Applications for Bioenergetic Research
- (2009) Valdur Saks et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Drug Resistance in Visceral Leishmaniasis
- (2009) Helena C. Maltezou JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- Roles of Trypanothione S-Transferase and Tryparedoxin Peroxidase in Resistance to Antimonials
- (2008) S. Wyllie et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Evolutionary conservation of RNA editing in the genus Leishmania
- (2008) Muntaser E. Ibrahim et al. INFECTION GENETICS AND EVOLUTION
- Systems analysis of metabolism in the pathogenic trypanosomatid Leishmania major
- (2008) Arvind K Chavali et al. Molecular Systems Biology
- Leishmania: conserved evolution – diverse diseases
- (2008) Miriam A. Lynn et al. TRENDS IN PARASITOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started